<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Neurologic Oncology News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/389</link> 
<description>Neurologic Oncology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985671</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Cancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985671</guid>
</item> 
 

<item> 
<title><![CDATA[Acyl-CoA Synthetase VL3 Knockdown Inhibits Human Glioma Cell Proliferation and Tumorigenicity]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985667</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Cancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985667</guid>
</item> 


 

<item> 
<title><![CDATA[Mutant Metabolic Enzymes Are at the Origin of Gliomas]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985663</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Cancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985663</guid>
</item> 
 
 


  


</channel> 
</rss>

